Gudonis Elenowitz Myomo NYSE

Myomo Deal Team Discusses Execution Strategy

The Regulation A deal team of medical device company Myomo (MYO), told a packed room last week at the Marcum Microcap conference in New York City that institutional investor thought their new mini-IPO deal wouldn’t trade in the secondary market so they wouldn’t invest.


Senior Exec, Directors Flee YayYo Amidst Promotion, Disclosure Concerns

A California tech start-up currently in the market with a $50 million Regulation A offering called YayYo has seen an exodus of senior leadership this month amid a storm of criticism over the company’s promotional campaign, which has included cable TV ads and online videos by rappers and TV character actors extolling investment in the company’s stock as an opportunity for retail investors to get in on the next Uber or Lyft.